Summary. Background: Severe postpartum hemorrhages (PPH) represent a significant cause of maternal morbidity/ mortality, but little is known about its hemostasis-related risk factors. Among the 32 463 women enrolled in the NOHA First cohort, 317 developed severe PPH (S-PPH group), 1269 nonsevere PPH (NS-PPH group) and the remaining individuals were considered as control women (C group). Methods: We performed a case-control study, including 317 triplets of women allocated from the three groups that shared the same clinical characteristics as the S-PPH group. Results: From values obtained 6-9 months after delivery, low (but notdeficient) levels of fibrinogen, von Willebrand factor (VWF) antigen, factor (F) XI, platelet CD42b, TRAP-induced increase of platelet CD41a and high values of serum residual prothrombin activity or closure aperture times using the collagen-ADP cartridge on the PFA-100 Ò system, and blood group O, were independently associated with a significant risk of severe PPH. Being positive for at least two of these eight variables was found in 1.6%, 3.5% and 20.8% of the women from the C, the NS-PPH and the S-PPH groups, respectively, the odds ratio for S-PPH in such a case being 16.4, 95%CI (6.5-41), P < 0.0001. Conclusions: Women with some hemostasis-related variables at the low or high end of the population distributions are prone to the severe forms of PPH. Clinical trials will allow us to know if acting on these risk factors can lower the clinical severity of PPH.
Severe postpartum haemorrhages (PPH) are responsible for maternal morbidity/mortality. Their complex management sometimes requires haemostatic supplementation, and therapeutic trials on fibrinogen or activated factor VII, which may add to the thrombotic risk, are currently being considered. Furthermore, there is a risk of venous thromboembolism (VTE) during the postpartum period, hence we studied the relationship between severe PPH and VTE in women during their first pregnancy. Among the 32,463 women enrolled between January 1, 1999 and February 1, 2004 in the NOHA First cohort, 317 developed severe PPH, 11 postpartum VTE and 60 had postpartum superficial vein thrombosis (SVT). In the women with severe PPH, whilst there were no episodes of VTE, there were three episodes of SVT, which occurred 6 weeks postpartum. All of the women with severe PPH received packed red blood cell (RBC) units, 29 (9.1%) platelets units, 51 (16.1%) fresh frozen plasma and 29 (9.1%) fibrinogen concentrates. Three patients with both severe PPH and SVT received only packed RBC. Severe PPH or packed RBC unit transfusion were associated with postpartum SVT (adjusted relative risk: 5.3 (1.6-17) and 4.7 (1.5-15) respectively), independent of caesarean section delivery and low-molecular-weight heparin (LMWH) use in the postpartum, but were not independent indicators of one another. This the VTE and SVT risks associated with severe PPH are low (<1% and <2%, respectively). Severe PPH increases the risk of postpartum SVT, but transfusion with platelet units and plasma supplementation using fresh frozen plasma or fibrinogen concentrates do not markedly modulate the risk of venous thrombosis.
The purpose of the studywas to compare cardiac output (CO) measurement by continuous (CTD) with that by conventional thermodilution (TD) were -0.2 and -0.3 and-0.8 L" min -1" m -2 and limits of agreement were 0.3, 0.7 and L6 L. rain -1" ra -2 for low (<2.5 L" rain -1" m-2), normal (between 2.5 and 4.5 L" min -t" m -z) and high (~ 4.5 L" rain -t" m -z) ~ -0,2, -0,3 et -0,8 L" rain -1" m -2 et les intervalles de confiance ~ 0,3, 0,7 et 1,6 L' min -1" m -z, respectivement pour les index cardiaques bas (<2,5 L'min-t'm-Z), normaux (entre 2,5 et 4,5 L" min -l" m -2) et hauts (>4,5 L" min -t" m-Z). La thermodilution continue, comparJe ~ la thermodilution classique, est une rr~thode fiable pour le monitorage du d~bit cardiaque surtout pour les index cardiaque _<4,5 L" min -!" m -z.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.